Differentiating between Alzheimer Disease Patients and Controls with Phase-difference-enhanced Imaging at 3T: A Feasibility Study

Access this Article

Search this Article

Author(s)

    • Tateishi Machiko
    • Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University
    • Yamashita Yasuyuki
    • Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University
    • Kitajima Mika
    • Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University
    • Hirai Toshinori
    • Department of Radiology, Faculty of Medicine, University of Miyazaki
    • Yoneda Tetsuya
    • Department of Medical Physics in Advanced Biomedical Sciences, Faculty of Life Sciences, Kumamoto University
    • Hashimoto Mamoru
    • Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University
    • Kurehana Nan
    • Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University
    • Uetani Hiroyuki
    • Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University
    • Fukuhara Ryuji
    • Department of Neuropsychiatry, Faculty of Life Sciences, Kumamoto University
    • Azuma Minako
    • Department of Radiology, Faculty of Medicine, University of Miyazaki

Abstract

<p>Purpose: To test the feasibility of the phase difference enhanced (PADRE) imaging for differentiation between Alzheimer disease (AD) patients and control subjects on 3T MR imaging.</p><p>Materials and Methods: Fifteen patients with AD and 10 age-matched control subjects underwent two-dimensional fast field echo imaging to obtain PADRE images on a 3T MR scanner. A double Gaussian distribution model was used to determine the threshold phase value for differentiation between the physiologic and non-physiologic iron in the cerebral cortices, and PADRE images were processed with the threshold. Using a 4-point grading system, two readers independently assessed the signal of the four cerebral cortices on PADRE images: the cuneus, precuneus, superior frontal gyrus, and superior temporal gyrus. The difference in the signals in each cortex between the AD patients and age-matched control subjects was determined by using Mann–Whitney U test. Inter-rater reliability was determined by Kappa analysis. We also evaluated the correlation between Mini-Mental State Examination (MMSE) score and the hypointense grade, and between disease duration and the hypointense grade using the Spearman rank correlation test.</p><p>Results: The threshold phase value for differentiation between the physiologic and non-physiologic iron was −4.6% π (radian). The mean grades of the cuneus, precuneus, and superior temporal gyrus were significantly higher for the AD patients than for the control subjects (<i>P</i> = 0.002). Excellent inter-rater reliability was seen in the precuneus (kappa = 0.93), superior temporal gyrus (kappa = 0.94), and superior frontal gyrus (kappa = 0.93); good inter-rater reliability was observed in the cuneus (kappa = 0.75). We found a statistical correlation between MMSE score and the hypointense grade in superior temporal gyrus (STG) (<i>P</i> = 0.008), and no correlation between disease duration and the hypointense grade in any gyrus.</p><p>Conclusion: Our results suggest the feasibility of PADRE imaging at 3T for differentiation between AD patients and control subjects.</p>

Journal

  • Magnetic Resonance in Medical Sciences

    Magnetic Resonance in Medical Sciences 17(4), 283-292, 2018

    Japanese Society for Magnetic Resonance in Medicine

Codes

Page Top